Live stream preview

Next video will start in 30 seconds

Can-Fite BioPharma Ltd. (NYSE American: CANF)

Close Open

CIIX High Growth Investment Opportunity Targeting Chinese Speaking Communities

Investing - Small-Cap Market Intelligence • 11m

Up Next in Investing - Small-Cap Market Intelligence

  • Can-Fite BioPharma Ltd. (NYSE America...

    Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical-stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Rheumatoid Arthritis and Psoriasis, and liver diseases includi...

  • Ethema Health: New Paradigm in Mental...

    Ethema Health Corporation (OTCQB: GRST) operates in the behavioral healthcare space, specifically in the treatment of substance-use disorders. The company has developed a unique treatment model that has shown to be highly effective at treating opioid addiction. Launched in 2011, Ethema plans to o...

  • Cyclo Therapeutics (CTDH)

    Cyclo Therapeutics (CTDH) is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The Company’s Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is used to treat Niemann-Pick Disease Type C (NPC), a rare...